首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease
【2h】

Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease

机译:1型Gaucher病患者的黄斑神经节细胞复合物和围毛绒视网膜神经纤维层稀疏

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Type-1 Gaucher disease (GD1) is considered to be non- neuronopathic however recent evidence of neurological involvement continues to accumulate. There is limited evidence of retinal abnormalities in GD1. The purpose of this study was to evaluate the retinal findings of patients with GD1. Thirty GD1 individuals and 30 healthy volunteers between the ages 40–75 years were prospectively enrolled. Macular and optic nerve optical coherence tomography (OCT) scans of both eyes of each patient were performed and thickness maps were compared between groups. Patients with a known neurodegenerative disease, glaucoma, high myopia and previous intraocular surgeries were excluded. It was shown that patients with GD1 presented with higher incidence of abnormal pRNFL OCT scan and showed significantly thinner areas of pRNFL and macular ganglion cell complex (GCC) when compared to a healthy control population. Changes in retinal thickness were not associated with GD1 genotype, treatment status, disease monitoring biomarker (lyso-Gb1) and severity score index (Zimran SSI). Further investigations are needed to determine whether these findings possess functional visual implications and if retinal thinning may serve as biomarker for the development of future neurodegenerative disease in this population.
机译:1型Gaucher疾病(GD1)被认为是非神经病,但最近的神经参与证据继续积累。在GD1中存在有限的视网膜异常证据。本研究的目的是评估GD1患者的视网膜结果。在40-75岁之间的三十个GD1个人和30岁之间的30个健康志愿者进行了预订。在对每个患者的两只眼睛的扫描进行黄斑和视神经光学相干断层扫描(OCT)扫描,并且在组之间比较厚度图。患有已知神经变性疾病,青光眼,高近视和先前的眼内手术的患者被排除在外。结果表明,与健康对照人群相比,患有GD1的GD1的患者具有较高的异常发生的异常发病率,并且显示出PRNFL和黄斑神经节细胞复合物(GCC)的显着较薄的区域。视网膜厚度的变化与GD1基因型,治疗状态,疾病监测生物标志物(Lyso-GB1)和严重程度评分指数(Zimran SSI)无关。需要进一步调查来确定这些发现是否具有功能性视觉影响,并且如果视网膜变薄可以作为这种人群中未来神经退行性疾病的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号